The Design and Rationale of the Trail1 Trial: A Randomized Double-Blind Phase 2 Clinical Trial of Pirfenidone in Rheumatoid Arthritis-Associated Interstitial Lung Disease

Overview of attention for article published in Advances in Therapy, September 2019

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (78th percentile)
High Attention Score compared to outputs of the same age and source (83rd percentile)

So far, Altmetric has seen 10 X posts from 9 X users, with an upper bound of 18,015 followers.

RT @AdvancesTherapy: Study protocol for TRAIL1 which is a phase 2 clinical trial of pirfenidone in rheumatoid arthritis-associated intersti…

RT @AdvancesTherapy: The TRAIL1 study protocol from @RheumILD and colleagues is now online - pirfenidone in rheumatoid arthritis-associated…

RT @AdvancesTherapy: The TRAIL1 study protocol from @RheumILD and colleagues is now online - pirfenidone in rheumatoid arthritis-associated…

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 6 additional X posts.